Recombinant batroxobin (Beijing Gerui Tesen Biomedical Technology)
重组巴曲酶（北京格瑞特森生物医药科技）
Report date: 2026/05/13 20:02:10
Base Information
Drug NameRecombinant batroxobin (Beijing Gerui Tesen Biomedical Technology)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBeijing Gerui Tesen Biomedical Technology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesBeijing Gerui Tesen Biomedical Technology Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A